{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:26:12Z","timestamp":1770146772238,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005267","name":"Center for Substance Abuse Treatment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005267","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jsat.2020.108216","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T02:43:14Z","timestamp":1606876994000},"page":"108216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["COVID-19 and treating incarcerated populations for opioid use disorder"],"prefix":"10.1016","volume":"124","author":[{"given":"Christopher J.","family":"Donelan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth A.","family":"Potee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levin","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2020.108216_bb0005","author":"American Civil Liberties Union of Massachusetts (ACLUM)"},{"issue":"9","key":"10.1016\/j.jsat.2020.108216_bb0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108216_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1108\/IJPH-08-2016-0039","article-title":"Addressing excess risk of overdose among recently incarcerated people in the USA: Harm reduction interventions in correctional settings","volume":"13","author":"Brinkley-Rubinstein","year":"2017","journal-title":"International Journal of Prisoner Health"},{"key":"10.1016\/j.jsat.2020.108216_bb0020","doi-asserted-by":"crossref","first-page":"107514","DOI":"10.1016\/j.drugalcdep.2019.06.016","article-title":"The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting","volume":"205","author":"Brinkley-Rubinstein","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108216_bb0025","author":"Commonwealth of Massachusetts"},{"key":"10.1016\/j.jsat.2020.108216_bb0030","author":"COVID Prison Project"},{"key":"10.1016\/j.jsat.2020.108216_bb0035","series-title":"Helping men recover: A program for treating addiction. Facilitator\u2019s guide and Participant\u2019s workbook","author":"Covington","year":"2011"},{"key":"10.1016\/j.jsat.2020.108216_bb0040","author":"Evans","year":"2019"},{"key":"10.1016\/j.jsat.2020.108216_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-16257-3_9","article-title":"The natural history, clinical course, and long-term recovery from opioid use disorders","author":"Evans","year":"2019"},{"key":"10.1016\/j.jsat.2020.108216_bb0050","series-title":"Massachusetts justice community opioid innovation network (mass JCOIN). Funded by the NIH National Institute on Drug Abuse (NIDA). Grant No. 1UG1DA050067-01","author":"Friedmann","year":"2019"},{"key":"10.1016\/j.jsat.2020.108216_bb0055","doi-asserted-by":"crossref","first-page":"102768","DOI":"10.1016\/j.drugpo.2020.102768","article-title":"A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system [published online ahead of print, 2020 May 20]","volume":"81","author":"Grella","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.jsat.2020.108216_bb0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HRP.0000000000000052","article-title":"Long-term course of opioid addiction","volume":"23","author":"Hser","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.jsat.2020.108216_bb0065","author":"Johns Hopkins University"},{"key":"10.1016\/j.jsat.2020.108216_bb0070","author":"Mace"},{"key":"10.1016\/j.jsat.2020.108216_bb0075","doi-asserted-by":"crossref","first-page":"107858","DOI":"10.1016\/j.drugalcdep.2020.107858","article-title":"Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails","volume":"208","author":"Macmadu","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.jsat.2020.108216_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003002","article-title":"Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review","volume":"16","author":"Malta","year":"2019","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jsat.2020.108216_bb0085","unstructured":"Massachusetts Department of Public Health, Bureau of Substance Addiction Services. (2020). Alert regarding COVID-19 for opioid treatment programs. Issued March 18, 2020."},{"key":"10.1016\/j.jsat.2020.108216_bb0090","author":"Massachusetts Emergency Management Agency"},{"key":"10.1016\/j.jsat.2020.108216_bb0095","doi-asserted-by":"crossref","first-page":"102819","DOI":"10.1016\/j.drugpo.2020.102819","article-title":"The perfect storm: COVID-19, mass incarceration and the opioid epidemic","volume":"11","author":"Mukherjee","year":"2020","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2020.108216_bb0100","unstructured":"National Council of Behavioral Health. (2020). Medication assisted treatment for opioid use disorder in jails and prisons. https:\/\/www.thenationalcouncil.org\/medication-assisted-treatment-for-opioid-use-disorder-in-jails-and-prisons\/ Accessed 2 October 2020."},{"issue":"7","key":"10.1016\/j.jsat.2020.108216_bb0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2105\/AJPH.2020.305707","article-title":"COVID-19 exposes need for progressive criminal justice reform","volume":"110","author":"Nowotny","year":"2020","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2020.108216_bb0110","author":"O'\u2019Neill Institute"},{"key":"10.1016\/j.jsat.2020.108216_bb0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.drugalcdep.2018.04.034","article-title":"Beyond the walls: Risk factors for overdose mortality following release from the Philadelphia Department of Prisons","volume":"189","author":"Pizzicato","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2020.108216_bb0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.drugalcdep.2004.12.005","article-title":"Utilizing recovery management checkups to shorten the cycle of relapse, treatment reentry, and recovery","volume":"78","author":"Scott","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2020.108216_bb0125","doi-asserted-by":"crossref","DOI":"10.2196\/12493","article-title":"Technological interventions for medication adherence in adult mental health and substance use disorders: A systematic review","volume":"6","author":"Steinkamp","year":"2019","journal-title":"JMIR Mental Health"},{"issue":"19","key":"10.1016\/j.jsat.2020.108216_bb0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.15585\/mmwr.mm6919e1","article-title":"COVID-19 in correctional and detention facilities - United States, February-April 2020","volume":"69","author":"Wallace","year":"2020","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2020.108216_bb0135","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States","author":"Wang","year":"2020","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jsat.2020.108216_bb0140","doi-asserted-by":"crossref","unstructured":"Wurcel, A. G., Dauria, E., Zaller, N., Nijhawan, A., Beckwith, C., Nowotny, K., & Brinkley-Rubinstein, L. (2020). Spotlight on jails: COVID-19 mitigation policies needed now. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America, ciaa346. Advance online publication. doi:https:\/\/doi.org\/10.1093\/cid\/ciaa346.","DOI":"10.1093\/cid\/ciaa346"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220304736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220304736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:54:09Z","timestamp":1760039649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547220304736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":28,"alternative-id":["S0740547220304736"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108216","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and treating incarcerated populations for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108216"}}